Indeed, it has been shown to induce NKG2C+ induced pluripotent stem cell (iPSC)-derived NK cell degranulation, IFN-γ production and proliferation of NKG2C+ subsets in AML cell lines and primary AML cells. Here, KLRC2 is linked to acute myeloid leukemia.